MOA
MYCOPHENOLIC ACID
Created: | 2001-08-10 |
Last modified: | 2021-03-13 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 43 |
Chiral Atom Count | 0 |
Bond Count | 44 |
Aromatic Bond Count | 6 |
Chemical Component Summary | |
---|---|
Name | MYCOPHENOLIC ACID |
Synonyms | 6-(1,3-DIHYDRO-7-HYDROXY-5-METHOXY-4-METHYL-1-OXOISOBENZOFURAN-6-YL)-4-METHYL-4-HEXANOIC ACID |
Systematic Name (OpenEye OEToolkits) | (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methyl-hex-4-enoic acid |
Formula | C17 H20 O6 |
Molecular Weight | 320.337 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C1OCc2c1c(O)c(c(OC)c2C)C\C=C(/C)CCC(=O)O |
SMILES | CACTVS | 3.341 | COc1c(C)c2COC(=O)c2c(O)c1CC=C(C)CCC(O)=O |
SMILES | OpenEye OEToolkits | 1.5.0 | Cc1c2c(c(c(c1OC)CC=C(C)CCC(=O)O)O)C(=O)OC2 |
Canonical SMILES | CACTVS | 3.341 | COc1c(C)c2COC(=O)c2c(O)c1C\C=C(C)\CCC(O)=O |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | Cc1c2c(c(c(c1OC)C\C=C(/C)\CCC(=O)O)O)C(=O)OC2 |
InChI | InChI | 1.03 | InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+ |
InChIKey | InChI | 1.03 | HPNSFSBZBAHARI-RUDMXATFSA-N |
Drug Info: DrugBank
DrugBank ID | DB01024 |
---|---|
Name | Mycophenolic acid |
Groups |
|
Description | Mycophenolic acid is a potent immunosuppressant agent that inhibits _de novo_ purine biosynthesis.[L42165] It was derived from _Penicillium stoloniferum_, and has also shown antibacterial, antifungal and antiviral properties.[A249170]. Mycophenolic acid is used in immunosuppressive regimens as part of a triple therapy that includes a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone.[A249175] This regimen can be used in place of the older anti-proliferative [azathioprine] due to its stronger immunosuppressive potency.[A249180] However, mycophenolic acid treatment is more expensive and requires therapeutic drug monitoring to optimize efficacy and minimize toxicity.[A249180,A249185] Mycophenolic acid is available as enteric-coated tablets of delayed-release, in an effort to improve upper gastrointestinal adverse events by delaying mycophenolic acid release until it reaches the small intestine.[A249190] [Mycophenolate mofetil], a prodrug of mycophenolic acid, is also prescribed to transplant recipients to prevent organ rejection.[L42020] |
Synonyms |
|
Brand Names |
|
Indication | Mycophenolic acid is an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant. Mycophenolic acid is used in combination with cyclosporine and corticosteroids.[L42165] |
Categories |
|
ATC-Code | L04AA06 |
CAS number | 24280-93-1 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Inosine-5'-monophosphate dehydrogenase 2 | MADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVD... | unknown | inhibitor |
Inosine-5'-monophosphate dehydrogenase 1 | MADYLISGGTGYVPEDGLTAQQLFASADGLTYNDFLILPGFIDFIADEVD... | unknown | inhibitor |
UDP-glucuronosyltransferase 2B7 | MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRG... | unknown | substrate |
UDP-glucuronosyltransferase 1A8 | MARTGWTSPIPLCVSLLLTCGFAEAGKLLVVPMDGSHWFTMQSVVEKLIL... | unknown | substrate |
UDP-glucuronosyltransferase 1A9 | MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL... | unknown | substrate |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL866 |
PubChem | 446541 |
ChEMBL | CHEMBL866 |
ChEBI | CHEBI:168396, CHEBI:92545 |
CCDC/CSD | XAVTEW, MYCPHA02 |